GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
114 hedge funds and large institutions have $357M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+1
Holders Change %
+0.88%
% of All Funds
2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
41
Reduced
28
Closed
13
Calls
$2.8M
Puts
$2.47M
Net Calls
+$334K
Net Calls Change
-$415K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$58.8M |
| 2 |
2
Fisher Asset Management
Camas,
Washington
|
$23.3M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$30.1M |
| 4 |
4
Goldman Sachs
New York
|
$9.23M |
| 5 |
5
Nordea Investment Management
Stockholm,
Sweden
|
$5.45M |
